AfyaIndex
Kenyan Reference & Directory
Free lookups today: 0/3 · Unlimited with Pro Subscribe from KES 99
Free lookups: 0/3 Unlimited with Pro → Browse by class Interactions · Tip: type at least 2 letters, then pick a result
← New search | Esomeprazole/Levofloxacin/ Amoxicillin

INN monograph

Esomeprazole/Levofloxacin/ Amoxicillin

Beta-lactam antibiotic — penicillin · POM

POM Source-linked Grade A

Source-linked · Updated 03 Aug 2026 · Source: Local active-ingredient clinical extract; FDA drug label via OpenFDA/DailyMed; Component monographs (multi-source pipeline); Professional class pharmacology (Beta-lactam antibiotic — penicillin)

Kenya market

Wholesale / list prices where loaded

From
KES 3,544
Median
KES 3,544
Brands
1

Risk first

Contraindications

  • History of serious immediate hypersensitivity (e.g. anaphylaxis, angioedema, urticaria) to any penicillin.
  • Caution with prior severe cephalosporin reaction (cross-reactivity risk).
  • Avoid in infectious mononucleosis if using aminopenicillins (rash risk).

Precautions

  • Warnings Allergy alert : Do not use if you are allergic to esomeprazole.
  • Esomeprazole may cause severe skin reactions.
  • Symptoms may include: skin reddening blisters rash If an allergic reaction occurs, stop use and seek medical help right away.

Point of care

Dosing

Adult

Directions adults 18 years of age and older this product is to be used once a day (every 24 hours), every day for 14 days may take 1 to 4 days for full effect 14-Day Course of Treatment • swallow 1 tablet with a glass of water before eating in the morning • take every day for 14 days • do not take more than 1 tablet a day • swallow whole. Do not crush or chew capsules. • do not use for more than 14 days unless directed by your doctor Repeated 14-Day Courses (if needed) • you may repeat a 14-day course every 4 months • do not take for more than 14 days or more often than every 4 months unless directed by a doctor children under 18 years of age: ask a doctor before use. Heartburn in children may sometimes be caused by a serious condition .

Paediatric

See label paediatric section if present; otherwise use paediatric formulary — do not extrapolate adult doses.

Renal

Renal excretion dominant — reduce dose or extend interval in significant renal impairment; risk of accumulation and seizures at high levels.

  • CrCl 0–120: Confirm renal dosing in product SmPC / primary label.

Hepatic

Low intrinsic hepatotoxicity; cholestatic hepatitis rare (notably flucloxacillin/co-amoxiclav patterns for related agents).

Safety

Drug interactions

Open checker →
  • Fixed-dose/multi-ingredient product.
  • Clinical details partially inherited from component monographs: Esomeprazole, Levofloxacin, Amoxicillin.
  • Confirm combination SmPC for exact dosing.

Safety

Adverse effects

  • Common: gastrointestinal upset, diarrhoea, mild rash.
  • Serious: anaphylaxis, Stevens–Johnson syndrome / TEN (rare), antibiotic-associated colitis (including C. difficile), interstitial nephritis, haematological reactions with prolonged high dose.

Use

Indications

  • Uses treats frequent heartburn (occurs 2 or more days a week) not intended for immediate relief of heartburn
  • this drug may take 1 to 4 days for full effect Clinical selection for Esomeprazole/Levofloxacin/ Amoxicillin should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC.
  • Class context: Beta-lactam antibiotic — penicillin.
  • Confirm site-specific dose, duration and monitoring before prescribing.

Pharmacology

Mode of action

The antibiotics act against helicobacter pylori and proton pump inhibitors reduce the acid in the stomach and help to heal the ulcer.

Inhibit H+/K+-ATPase ↓ Acid secretion Mucosal healing support
Full mechanism text

The antibiotics act against helicobacter pylori and proton pump inhibitors reduce the acid in the stomach and help to heal the ulcer. Hence, the combination is more effective than single antibiotic or a proton pump inhibitor alone.

ADME

Pharmacokinetics & PD

Onset Within 1 hour (oral); faster IV
Duration 4–8 hours typical (agent/formulation dependent)
Route ORAL / PARENTERAL (agent-dependent)
Elimination is predominantly renal (glomerular filtration and tubular secretion). Dose adjustment is often required in severe renal impairment. Probenecid reduces tubular secretion and prolongs levels.
Half-life differ by agent and salt/ester. Most penicillins distribute widely into extracellular fluid; CSF penetration is poor unless meninges are inflamed.
Full PK/PD text

Absorption, protein binding and half-life differ by agent and salt/ester. Most penicillins distribute widely into extracellular fluid; CSF penetration is poor unless meninges are inflamed. Elimination is predominantly renal (glomerular filtration and tubular secretion). Dose adjustment is often required in severe renal impairment. Probenecid reduces tubular secretion and prolongs levels.

Kenya

Brands & prices

1 listed
Brand Company Pack KES
ESOSE HP KIT DAIMA BIASHARA / Wholesale Import 3,544.44

Special populations

Pregnancy & lactation

Pregnancy

Penicillins are generally considered compatible in pregnancy when clearly indicated (decades of clinical use). Prefer agents with the best safety record for the indication; confirm current SmPC.

Lactation

[From component Levofloxacin] 8.3 Nursing Mothers Based on data on other fluoroquinolones and very limited data on levofloxacin, it can be presumed that levofloxacin will be excreted in human milk. Because of the potential for serious adverse reactions from levofloxacin in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Diet

Food & alcohol

  • Food
  • Food

Trust

Sources & disclaimer

Source: Local active-ingredient clinical extract; FDA drug label via OpenFDA/DailyMed; Component monographs (multi-source pipeline); Professional class pharmacology (Beta-lactam antibiotic — penicillin)

Open source link

Clinical review date not recorded.

Decision support only — not a substitute for clinical judgment, product SmPC, or Kenya STG/EML.

AfyaIndex dataset coverage